Damien Drubay

Title: Damien Drubay: Innovator in Breast Cancer Prognosis

Introduction

Damien Drubay is a notable inventor based in Paris, France. He has made significant contributions to the field of medical technology, particularly in breast cancer prognosis. His innovative work focuses on utilizing machine learning to enhance predictive capabilities in cancer treatment.

Latest Patents

Damien Drubay holds a patent for "Systems and methods for determining breast cancer prognosis and associated features." This patent describes a computer-implemented method and a machine learning model designed to predict the likelihood of relapse in breast cancer patients following treatment. Additionally, it includes the ability to predict tumors within whole slide images and assess biomarker status in breast cancer tissue. He has 1 patent to his name.

Career Highlights

Throughout his career, Damien has worked with prominent companies in the medical technology sector, including Owkin France SAS and Owkin, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer prognosis.

Collaborations

Damien has collaborated with talented individuals in his field, including Charlie Saillard and Benoit Schmauch. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in healthcare.

Conclusion

Damien Drubay is a pioneering inventor whose work in breast cancer prognosis exemplifies the intersection of technology and medicine. His contributions are vital in improving patient outcomes and advancing the field of oncology.